IT1058295BIT1926475AIT1926475AIT1058295BIT 1058295 BIT1058295 BIT 1058295BIT 1926475 AIT1926475 AIT 1926475AIT 1926475 AIT1926475 AIT 1926475AIT 1058295 BIT1058295 BIT 1058295B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco InstfiledCriticalLuso Farmaco Inst
Priority to IT1926475ApriorityCriticalpatent/IT1058295B/it
Priority to US05/545,946prioritypatent/US3988475A/en
Priority to FR7503404Aprioritypatent/FR2259594B1/fr
Priority to ES434421Aprioritypatent/ES434421A1/es
Priority to GB4926/75Aprioritypatent/GB1500734A/en
Priority to NL7501371.Aprioritypatent/NL162062C/xx
Priority to JP1522575Aprioritypatent/JPS5412458B2/ja
Priority to AU77888/75Aprioritypatent/AU483171B2/en
Priority to DE2504790Aprioritypatent/DE2504790C3/de
Priority to CA219,402Aprioritypatent/CA1052791A/en
Application grantedgrantedCritical
Publication of IT1058295BpublicationCriticalpatent/IT1058295B/it
Werkwijze voor het bereiden van een geneesmiddel met een anti-aritmische activiteit, gevormde geneesmiddelen ver- kregen door toepassing van deze werkwijze en werkwijze voor het bereiden van geneeskrachtige fenoxyalkylaminen, geschikt voor gebruik bij de voornoemde werkwijze.
N-(2-aroyl-phenyl)-2-alkylamino-imidazoles - as protecting agents for cerebral agents for cerebral anoxia and hypoxia and cerebral blood circulatory activators
Active compound combination of kitasamycin and quinoxalineprocess for preparing of active compound combination of ki di-n-oxides tasamycin and quinoxaline-di-x-oxides